Your browser doesn't support javascript.
loading
Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor.
Chen, Shumin; Li, Ye; Wang, Zheng; Feng, Lin; Jia, Yueping; Mo, Xiaodong; Wang, Yu; Jiang, Qian; Huang, Xiaojun; Lai, Yueyun.
Afiliação
  • Chen S; Peking University Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.
  • Li Y; Peking University Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.
  • Wang Z; Peking University Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.
  • Feng L; Peking University Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.
  • Jia Y; Department of Pediatrics, Peking University People's Hospital, Beijing 100044, China.
  • Mo X; Peking University Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.
  • Wang Y; Peking University Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.
  • Jiang Q; Peking University Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.
  • Huang X; Peking University Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.
  • Lai Y; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences (2019RU029), Beijing 100044, China.
Chin Med J (Engl) ; 136(11): 1382-1384, 2023 06 05.
Article em En | MEDLINE | ID: mdl-36806200
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article